Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10278923 Oral dosing of GLP-1 compounds

Patent 10278923 was granted and assigned to Novo Nordisk on May, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 9 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 9 Dec, 2023
Edits made to:
Article (+96 characters)
Article

Patent abstract

The present invention relates to improved uses of GLP-1 peptides in oral therapy.

Edits on 7 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Dec, 2023
Edits on 2 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 2 Oct, 2023
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Flemming S. Nielsen0
Per Sauerberg0
Edits on 20 Sep, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 20 Sep, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11759503 Compositions of GLP-1 peptides and preparation thereof
"update inverses"
Golden AI profile picture
Golden AI
edited on 20 Sep, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11759502 Compositions of GLP-1 peptides and preparation thereof
"update inverses"
Golden AI profile picture
Golden AI
edited on 20 Sep, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11759501 Compositions of GLP-1 peptides and preparation thereof
Edits on 25 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 25 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=10278923
Edits on 27 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Apr, 2023
Edits on 29 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 29 Mar, 2023
Edits on 23 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Mar, 2023
Edits on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Edits on 25 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Edits on 23 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Sep, 2022
Edits on 13 Jul, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 13 Jul, 2022
Edits on 18 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 18 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=10278923
Edits on 12 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 12 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11034746 Double-acylated GLP-1 derivatives
"update inverses"
Golden AI profile picture
Golden AI
edited on 12 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11033499 Tablet formulation comprising a GLP-1 peptide and a delivery agent
Edits on 11 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 11 Feb, 2022
Edits on 10 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 10 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10933120 Compositions of GLP-1 peptides and preparation thereof
Edits on 26 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 26 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 10278923 Oral dosing of GLP-1 compounds

Infobox
Is a
Patent
Patent
Patent applicant
Novo Nordisk
Novo Nordisk
Current assignee
Novo Nordisk
Novo Nordisk
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10278923
Date of patent
May 7, 2019
Patent application number
15651043
Date Filed
July 17, 2017
Patent primary examiner
‌
Shulamith H. Shafer

Find more entities like US Patent 10278923 Oral dosing of GLP-1 compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.